Selected research
Industry Research
Neurotensin Industry Research Report 2026
Market perspective
The global Neurotensin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Neurotensin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Neurotensin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Neurotensin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Neurotensin include APExBIO, Bio - Techne, Eurogentec, Genscript, MedChemExpress, Peptide Institute and PerkinElmer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Neurotensin market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neurotensin Market by Company
APExBIO
Bio - Techne
Eurogentec
Genscript
MedChemExpress
Peptide Institute
PerkinElmer
Neurotensin Segment by Type
Bovine
Canine
Human
Mouse
Neurotensin Segment by Application
Scientific Research
Medical
Others
Neurotensin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurotensin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurotensin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurotensin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Neurotensin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Neurotensin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Neurotensin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bovine
- Canine
- Human
- Mouse
Applications
- Scientific Research
- Medical
- Others
Companies covered
- APExBIO
- Bio - Techne
- Eurogentec
- Genscript
- MedChemExpress
- Peptide Institute
- PerkinElmer
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Neurotensin Market Size (2021-2032)
- 2.2.2 Global Neurotensin Sales (2021-2032)
- 2.2.3 Global Neurotensin Market Average Price (2021-2032)
- 2.3 Neurotensin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Bovine
- 2.3.3 Canine
- 2.3.4 Human
- 2.3.5 Mouse
- 2.4 Neurotensin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Scientific Research
- 2.4.3 Medical
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Neurotensin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Neurotensin Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Neurotensin Revenue of Manufacturers (2021-2026)
- 3.4 Global Neurotensin Average Price by Manufacturers (2021-2026)
- 3.5 Global Neurotensin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Neurotensin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Neurotensin, Product Type & Application
- 3.8 Global Manufacturers of Neurotensin, Established Date
- 3.9 Global Neurotensin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 APExBIO
- 4.1.1 APExBIO Company Information
- 4.1.2 APExBIO Business Overview
- 4.1.3 APExBIO Neurotensin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 APExBIO Neurotensin Product Portfolio
- 4.1.5 APExBIO Recent Developments
- 4.2 Bio - Techne
- 4.2.1 Bio - Techne Company Information
- 4.2.2 Bio - Techne Business Overview
- 4.2.3 Bio - Techne Neurotensin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bio - Techne Neurotensin Product Portfolio
- 4.2.5 Bio - Techne Recent Developments
- 4.3 Eurogentec
- 4.3.1 Eurogentec Company Information
- 4.3.2 Eurogentec Business Overview
- 4.3.3 Eurogentec Neurotensin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Eurogentec Neurotensin Product Portfolio
- 4.3.5 Eurogentec Recent Developments
- 4.4 Genscript
- 4.4.1 Genscript Company Information
- 4.4.2 Genscript Business Overview
- 4.4.3 Genscript Neurotensin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Genscript Neurotensin Product Portfolio
- 4.4.5 Genscript Recent Developments
- 4.5 MedChemExpress
- 4.5.1 MedChemExpress Company Information
- 4.5.2 MedChemExpress Business Overview
- 4.5.3 MedChemExpress Neurotensin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 MedChemExpress Neurotensin Product Portfolio
- 4.5.5 MedChemExpress Recent Developments
- 4.6 Peptide Institute
- 4.6.1 Peptide Institute Company Information
- 4.6.2 Peptide Institute Business Overview
- 4.6.3 Peptide Institute Neurotensin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Peptide Institute Neurotensin Product Portfolio
- 4.6.5 Peptide Institute Recent Developments
- 4.7 PerkinElmer
- 4.7.1 PerkinElmer Company Information
- 4.7.2 PerkinElmer Business Overview
- 4.7.3 PerkinElmer Neurotensin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 PerkinElmer Neurotensin Product Portfolio
- 4.7.5 PerkinElmer Recent Developments
5 Global Neurotensin Market Scenario by Region
- 5.1 Global Neurotensin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Neurotensin Sales by Region: 2021-2032
- 5.2.1 Global Neurotensin Sales by Region: 2021-2026
- 5.2.2 Global Neurotensin Sales by Region: 2027-2032
- 5.3 Global Neurotensin Revenue by Region: 2021-2032
- 5.3.1 Global Neurotensin Revenue by Region: 2021-2026
- 5.3.2 Global Neurotensin Revenue by Region: 2027-2032
- 5.4 North America Neurotensin Market Facts & Figures by Country
- 5.4.1 North America Neurotensin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Neurotensin Sales by Country (2021-2032)
- 5.4.3 North America Neurotensin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Neurotensin Market Facts & Figures by Country
- 5.5.1 Europe Neurotensin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Neurotensin Sales by Country (2021-2032)
- 5.5.3 Europe Neurotensin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Neurotensin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Neurotensin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Neurotensin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Neurotensin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Neurotensin Market Facts & Figures by Country
- 5.7.1 South America Neurotensin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Neurotensin Sales by Country (2021-2032)
- 5.7.3 South America Neurotensin Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Neurotensin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Neurotensin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Neurotensin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Neurotensin Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Neurotensin Sales by Type (2021-2032)
- 6.1.1 Global Neurotensin Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Neurotensin Sales Market Share by Type (2021-2032)
- 6.2 Global Neurotensin Revenue by Type (2021-2032)
- 6.2.1 Global Neurotensin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Neurotensin Revenue Market Share by Type (2021-2032)
- 6.3 Global Neurotensin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Neurotensin Sales by Application (2021-2032)
- 7.1.1 Global Neurotensin Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Neurotensin Sales Market Share by Application (2021-2032)
- 7.2 Global Neurotensin Revenue by Application (2021-2032)
- 7.2.1 Global Neurotensin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Neurotensin Revenue Market Share by Application (2021-2032)
- 7.3 Global Neurotensin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Neurotensin Value Chain Analysis
- 8.1.1 Neurotensin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Neurotensin Production Mode & Process
- 8.2 Neurotensin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Neurotensin Distributors
- 8.2.3 Neurotensin Customers
9 Global Neurotensin Analyzing Market Dynamics
- 9.1 Neurotensin Industry Trends
- 9.2 Neurotensin Industry Drivers
- 9.3 Neurotensin Industry Opportunities and Challenges
- 9.4 Neurotensin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst